澳华内镜：控股股东之一拟减持不超1.93%公司股份

Group 1 - The core point of the article is that Australia Huaren Endoscopy (688212) announced a plan for share reduction by its controlling shareholder and actual controller, Gu Xiaozhou, through centralized bidding and block trading, with a total reduction not exceeding 2.6 million shares, accounting for no more than 1.93% of the company's total share capital [1]